Ipswich Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Buy |
5,608
+90
| +2% | +$40.1K | 0.6% | 40 |
|
|
2025
Q1 | $2.68M | Buy |
5,518
+510
| +10% | +$247K | 0.66% | 40 |
|
|
2024
Q4 | $2.02M | Buy |
5,008
+3,485
| +229% | +$1.4M | 0.49% | 50 |
|
|
2024
Q3 | $708K | Buy |
1,523
+40
| +3% | +$18.6K | 0.16% | 107 |
|
|
2024
Q2 | $695K | Buy |
1,483
+190
| +15% | +$89.1K | 0.16% | 105 |
|
|
2024
Q1 | $540K | Buy |
1,293
+508
| +65% | +$212K | 0.13% | 126 |
|
|
2023
Q4 | $319K | Buy |
+785
| New | +$319K | 0.08% | 150 |
|
|
2021
Q3 | – | Sell |
-3,875
| Closed | -$781K | – | 200 |
|
|
2021
Q2 | $781K | Sell |
3,875
-2,445
| -39% | -$493K | 0.2% | 107 |
|
|
2021
Q1 | $1.36M | Buy |
+6,320
| New | +$1.36M | 0.38% | 75 |
|
|
2014
Q3 | – | Sell |
-3,685
| Closed | -$349K | – | 144 |
|
|
2014
Q2 | $349K | Sell |
3,685
-1,460
| -28% | -$138K | 0.14% | 106 |
|
|
2014
Q1 | $364K | Sell |
5,145
-8,966
| -64% | -$634K | 0.16% | 93 |
|
|
2013
Q4 | $1.05M | Sell |
14,111
-1,985
| -12% | -$147K | 0.44% | 58 |
|
|
2013
Q3 | $1.22M | Sell |
16,096
-369
| -2% | -$28K | 0.55% | 55 |
|
|
2013
Q2 | $1.32M | Buy |
+16,465
| New | +$1.32M | 0.57% | 57 |
|